INTRODUCTION
The amino acid sequence of a particular protein is specified by the sequence of nucleotides in a particular segment of the deoxyribonucleic acid (DNA). The process of protein synthesis consists of two stages. First, the DNA is transcribed into a ribonucleic acid (RNA) intermediate, messenger RNA (mRNA), which has a ribonucleotide sequence complementary to that of the deoxyribonucleotide sequence of one of the strands of the DNA serving as template (transcription) (120) . The mRNA becomes attached to cytoplasmic ribonucleoprotein particles (ribosomes) which are the sites of protein synthesis, and there it determines the order of linkage of amino acids into a specific protein (translation) (17, 243, 291) . The mRNA is translated in the 5' to 3' direction (291) . The synthesis of a protein is initiated at the amino-terminal amino acid and proceeds towards the carboxy-terminal amino acid (17, 32a, 84a, 243, 291) . During translation, a group of three adjacent nucleotides in the mRNA (codon) specifies which amino acid is to be linked to the growing peptide chain. It has been established which codons specify each of the 20 amino acids (74) . (This is the genetic code). It appears that the sequence of amino acids in a polypeptide chain contains all of the information required for generating the three-dimensional structure of the native protein molecule (chain folding) (13) . The topic of this review is restricted to certain aspects of the mechanism of translation, mainly, although not exclusively, as elucidated in microorganisms. The regulation of protein synthesis (99) is not discussed. A collection of significant investigations on mammalian protein synthesis was presented in a volume dedicated to the memory of R. Schweet (14) . Similar studies in plant systems have been described recently (5) .
Abbreviations Shorthand writing of oligonucleotides and polynucleotides and abbreviations for nucleotides, amino-acid residues, etc., are as recommended in J. Biol. Chem. 241:527 (1966) .
In addition to those identified in the text, abbreviations are used as follows: RNA capable of accepting, for example, glycine, tRNAGlY; aminoacyl-tRNA, AA-tRNA (e.g., Gly-tRNA); mischarged tRNA species, for example, AlatRNACYs; different tRNA species capable of accepting the same amino acid, isoaccepting tRNAs; N-acetyl AA-tRNA, acAA-tRNA (e.g., acPhe-tRNA); phe-phe-tRNA, diphe-tRNA; phephe-phe-tRNA, triphe-tRNA; aminoacyl oligonucleotides derived from AA-tRNA, for example, CpA-Gly or CACCA-acLeu; AA-tRNA synthetase aminoacyladenylate complex, E-AA-AMP; mRNA which is translated into more that one polypeptide, polygenic mRNA; polynucleotides with random sequence (e.g., a polymer containing adenylate, uridylate, and guanylate units), poly (A, U, G). Trinucleotide codons are shown by base initials (e.g., ApUpG, AUG).
Cell-free Protein Synthesizing Systems
In vitro systems have been a major tool for examining the mechanism of protein biosynthesis. They can be prepared (277) by disintegrating cells in aqueous media, removing unbroken cells and cell debris by low-speed centrifugation and small molecules by dialysis. To observe protein synthesis with such extracts, one requires the addition of adenosine triphosphate (ATP), guanosine triphosphate (GTP), an ATP-generating system, proper ions (Mg++ and either K+ or NH4+), sulfhydryl compounds (which were found to stabilize the system), and amino acids (some of which are usually radioactively labeled). In such a system, mRNA can be translated into protein.
The translation is assayed by following the incorporation of labeled amino acids into protein.
The messenger may be present in the extract (endogenous messenger), or it may be added (exogenous messenger). (In the latter case, the endogenous messenger is usually inactivated by incubating the extract before the amino acid incorporation experiment to provide time for the nucleases in the extract to degrade the endogenous mRNA.) The exogenous messenger can be either a natural or a synthetic polyribonucleotide. The use of synthetic polyribonucleotides of known composition or sequence was of utmost significance in deciphering the genetic code (214, 279, 280) .
The cell extract can be further fractionated by centrifugation at high speed. The resulting supernatant fraction contains the following compo-nents of the protein synthesizing machinery: tRNA (about 40 species), AA-tRNA synthetases (at least 20 species), and proteins involved in the elongation and termination of the peptide chain (at least 5 species). The resulting pellet contains: ribosomes (built from at least three kinds of ribosomal RNA and about 50 different kinds of ribosomal protein) and proteins required for peptide chain initiation (at least 3 species). The initiation factors can be removed from the ribosomes by washing with a buffer of high ionic strength. At this time more than 120 different macromolecules are known to be involved in the process of translation.
AA-tRNA SYNTHETASES In every organism in which this was tested, there exist at least 20 AA-tRNA synthetases which link the correct amino acid presumably to the 3'-hydroxyl (246, 356) of the terminal adenosine of a specific tRNA molecule (see section on tRNA). The formation of AA-tRNA catalyzed by the AA-tRNA synthetase is a two-step reaction involving activation and transfer. The product of the activation step is the enzyme-bound aminopyrophosphate (PP1) the enzyme catalyzes the breakdown of the complex to ATP and amino acid. The incorporation of 32PPj into ATP is commonly used to estimate the formation of E-AA-AMP (ATP-PPj exchange). Another assay is the reaction of E-AA-AMP with hydroxylamine to form the hydroxamate of the amino acid and AMP (see 307) . In the transfer step, the activated amino acid is transferred onto the tRNA (a transacylation) to form AA-tRNA, the production of which can be measured directly.
The specificity of AA-tRNA synthetases, a prerequisite for faithful translation of the genetic message, must be very high (223, 290, 307) and is exercised at the level of amino acid activation as well as in the transfer step. The specificity in the latter step is higher than in the former; i.e., besides activating their cognate amino acids, lle-tRNA synthetase activates valine and ValtRNA synthetase activates threonine (21, 29, 157) . These "wrong" amino acids are not then transferred to the tRNA, however. Certain amino acid analogues, however, do get charged onto tRNA (see 52, 274) and are subsequently incorporated into protein.
Although all of these enzymes perform the same function, there is no selective pressure to ensure that all of these molecules be very similar. Each aminoacyl-tRNA synthetase charges one or very few tRNA species. Consequently, mutations that change the mode of recognition between the enzyme and its substrates might be tolerated by the organism. Thus, the mode of recognition between the particular AA-tRNA synthetases and their substrates need not be the same, and a range of variation in physical and other characteristics of AA-tRNA synthetases does exist.
Since many aspects of AA-tRNA synthetases and amino acid activation have been discussed in 
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Mol wt (X 103) (S20,w) more detail previously (290, 307) , only a few selected points will be presented here. Isolation and Properties of AA-tRNA Synthetases To date, a large number of AA-tRNA synthetases from various sources have been purified (Table 1) . Most of the known enzymes have a molecular weight of around 100,000 (see Table 1 and reference 269). However, Phe-tRNA synthetases from yeast (234) and Escherichia coil (364) , as well as Ala-tRNA (269) and Met-tRNA (212) synthetases of E. coli, have a molecular weight of about 173 ,000. The amino acid composition of a number of AA-tRNA synthetases has been determined, but there is much less information about their physical structure. In a few cases, AA-tRNA synthetases have been dissociated by such reagents as urea or guanidinium chloride into subunits of molecular weight about 50,000. It is not known whether the subunits formed are identical or different. For Pro-tRNA synthetase, no enzymatic activity was found in subunits of molecular weight 47,000 (210) . The molecular weight of Met-tRNA synthetase purified from E. coli K was reported to be 173,000 (212) . On incubating this enzyme with a factor isolated from the 100,000-g pellet fraction of the crude extract, it is depolymerized into enzymatically active synthetase molecules of molecular weight 54,000. Treatment of the high-molecular-weight enzyme with dissociating agents (e.g., 8 M urea) results in subunits of molecular weight 43 ,000 whose enzymatic activity has not yet been determined (65) . MettRNA synthetase was also isolated (by a method different from the one used for the E. coli K enzyme) from another strain of E. coil [MRE 244 (47) ]. The molecular weight of this enzyme was reported as 96,000.
The kinetic parameters of the AA-tRNA synthetases, in the cases where they have been determined, seem to ve very similar. Measured in the overall reaction (aminoacylation of tRNA) the Km for the amino acid is between 10' and 10' M; for ATP, around 10' M; and for tRNA, between 10-7 and 10 M. The Km for ATP and amino acid in the activation step depends upon the nature of the assay and is different for the same AA-tRNA synthetase when measured by ATP-PPi exchange or by hydroxamate formation (see below). The various AA-tRNA synthetases have different optimal requirements for ATP, Me+, and other ions.
The kinetic methods in current use are still insufficiently precise and too slow to allow detailed unraveling of the exact sequence of reaction steps of amino acid activation (leading to E-AA-AMP formation) and tRNA acylation. In two cases, however, a complex of ATP and the AA-tRNA synthetase has been isolated. This might indicate that ATP is bound to the enzyme before the amino acid (4, 328) .
Some lines of evidence suggest that the site for amino acid activation is different from the site for amino acid transfer (64) . When E. coli MettRNA synthetase was treated with parahydroxymercuri benzoate (pHMB) in the presence of methioninyladenylate, a structural analogue of methionyladenylate, the enzyme retained the ability to activate methionine [as tested by ATP-PP1 exchange), but could no longer catalyze the formation of Met-tRNA. The reaction with pHMB did not alter the molecular weight of the enzyme. This suggests that the sites for the two reaction steps are different. "Cold" treatment of E. coli Pro-tRNA synthetase was reported to impair the transfer step to a much larger extent than the activation step (300) . Whether this is due to dissociation of the enzyme into subunits at low temperatures remains to be determined (210) .
Reaction Mechanism In the activation step the AA-tRNA synthetase catalyzes the formation of the aminoacyladenylate, which remains bound to the enzyme and does not accumulate as a free intermediate. The activation reaction can be followed readily by ATP-PPj exchange for all synthetases, but the product aminoacyladenylate is not always detected in the alternate assay (hydroxamate formation). This was demonstrated in a comparative study of 14 E. coli AA-tRNA synthetases (157) . The initial rates of the overall reaction (the formation of AA-tRNA) and of the activation step (the formation of hydroxylamine-sensitive aminoacyladenylate) were measured. For some enzymes, the same rate was observed by each assay, but for others, no hydroxamate formation was detectable. Thr-tRNA synthetase, for instance, forms threonyladenylate (as shown by ATP-PP1 exchange as well as by isolation of the E-Thr-AMP complex), but this does not react with hydroxylamine under standard conditions (156) . After the addition of tRNA, threonylhydroxamate is formed by a nonenzymatic reaction of Thr-tRNA with hydroxylamine. It was suggested that the threonyladenylate is buried inside the enzyme molecule, inaccessible to hydroxylamine. Similar lack of hydroxamate formation was shown for Thr-tRNA synthetase of calf liver (219) .
Although the formation of E-AA-AMP requires in most cases only the presence of amino acid, ATP, and Mg++, a few cases have been found in which the presence of tRNA is required for amino acid activation. Glu-tRNA synthetase from E. coli, pork liver, and yeast (209, 317) catalyzes glutamyladenylate formation only at very high glutamate concentrations. However, in the presence of tRNA, very low glutamate concentrations are sufficient for synthesis. The tRNAGlU is strictly required under any conditions for the formation of glutaminyladenylate by its cognate enzyme in the same three organisms. The same is true for E. coli Arg-tRNA synthetase (248) and rat liver Gly-tRNA synthetase (105) . In the latter case, however, the activation was measured only by hydroxamate formation, and thus the conclusion may be invalidated by the limitations of the hydroxamate method discussed above. It was reported that tRNA activates arginyl-adenylate formation catalyzed by Arg-tRNA synthetase (252) . It is possible that the apparent need for tRNA in amino acid activation in the case of certain synthetases, but not in that of others, reflects that the order of binding of the substrates (ATP, amino acid, tRNA) to the synthetases may not be the same for all enzymes.
The E-AA-AMP complex has been isolated by gel filtration for a variety of enzymes (4, 6, 33, 136, 200, 289, 397) . The isolated complex can be used in the elucidation of the reaction mechanism of the transfer step. Differences between enzymes are apparent in the requirement for inclusion of divalent metal ions in the reaction mixture in which the transfer of the amino acid from the complex onto the tRNA is tested. The transfer proceeds without metal ions in the case of E. col Ile-tRNA (289) (4) and from E. coli (156) , Ile-tRNA synthetase from Bacillus stearothermophilus (136) , and Ser-tRNA synthetase from yeast (33) . Some other divalent metal ions may substitute for Mg++ (156 (199, 200) and Leu-tRNA synthetase (341) , as well as with Ileand Tyr-tRNA synthetase from E. coli (418) and Arg-, Gly-, and Val-tRNA synthetase from B. stearothermophilus (294) . The tRNA-AA-tRNA synthetase complexes, isolated by gel filtration on Sephadex G-100, by sucrose density gradient centrifugation, and by electrophoresis, have been shown to be enzymatically active. If the stable complex is isolated on a membrane filter (Millipore Corp., Bedford, Mass.), however, the enzyme is completely inactivated (418) . The complex formation is usually specific for the tRNA and its cognate AA-tRNA synthetase. Lack of specificity has been observed (199) , however, at low salt concentrations. Complex formation between synthetases and tRNA from heterologous systems also occurs (294) .
Whether the acceptor end of the tRNA molecule is involved in this complex formation remains controversial (200, 293, 294) . In some cases, periodate-oxidized tRNA will not bind to or inhibit AA-tRNA synthetase, whereas the opposite is true in other cases. These findings suggest that the process of recognition between tRNA and its cognate AA-tRNA synthetase may vary from case to case.
Genetics of Synthetases
Mutants for a number of AA-tRNA synthetases have been isolated from or found in E. coli, Salmonella typhimurium, and yeast (see Table 2 ). The genetic loci of the E. coli AA-tRNA synthetases (as far as they have been determined) are scattered all over the chromosome. The temperature-sensitive synthetase mutants display little activity in in vitro tests even at low temperature, and some possess a decreased affinity for amino acid, ATP, or both. In some cases, they can be protected against heat denaturation by the presence of amino acid, ATP, or Mg++. Most of the present data on E. coli are consistent with the existence of only one AA-tRNA synthetase for each amino acid. It remains to be seen whether reports of several AA-tRNA synthetases for the same amino acid in E. coli (66, 420) could possibly be attributed to aggregates or to tRNA-AA-tRNA synthetase complexes (341) . In higher organisms, the occurrence of multiple synthetases (22, 164, 393) is partly accounted for by the recent discovery (24, 48) of different AAtRNA synthetases (specific for the same amino acid) in the mitochondria and the cytoplasm of the same cell. It has been shown that a mitochondrial Leu-tRNA synthetase is specified by a nuclear gene (137) .
TRANSFER RNA Sequence of tRNA Since the elucidation of the first tRNA sequence (160), great progress in tRNA fractionation techniques (126, 127) and sequencing methods (334) stimulated the pace of tRNA sequence analysis.
At present, the primary sequences of 17 tRNA species from bakers' (90, 160, 231, 273, 312) and brewers' (423) yeast, E. coli K-12 (76, 89, 129) and B (M. Uziel, unpublished data; U. L. RajBhandary, unpublished data), Torulopsis utilis (379, 380), rat liver (360) , and wheat germ (90) have been established. The chain length of the (85, 275) and tertiary (202) structure of tRNA have been 269 VOL. 33X -1969 made (114) , so far providing no really convincing evidence for any model. Recent progress in the crystallization of tRNA from E. coli and yeast (69, 78, 113, 146, 180) has encouraged the hope that the tertiary structure of tRNA will be determined by X-ray crystallography. Crystallization of the complex of tRNA and its cognate AAtRNA synthetase may prove even more illuminating.
Genetics of tRNA So far tRNA has been accessible for genetic studies only in very rare cases. Nonsense mutations of the amber and ochre type are known to cause premature peptide chain termination (117) , and their suppression in E. coil has been shown to be due in some cases to a suppressor tRNA (59, 97, 129, 130, 352, 411) . The anticodons of the tyrosine suppressor tRNA and of the corresponding tRNAtYr species from a strain not carrying the suppressor mutation differ in a single nucleotide (129) . This provides evidence for the assumption that the suppressor mutation occurred in the structural gene for the tRNA. The genetic loci for the suppressor tRNA are distributed all over the chromosome. Work on the regulation of histidine biosynthesis in S. typhimurium has revealed a class of mutants believed to be mutants in tRNAhis (347) .
Recognition of tRNA by the AA-tRNA Synthetase
The question of the specific recognition site on the tRNA for its cognate AA-tRNA synthetase is the oldest and still foremost open question in tRNA research. Whereas some earlier experiments were taken to support the view that the anticodon is a specific recognition site for the AA-tRNA synthetase (254) , there is mounting evidence that this may not be so, at least not for all tRNA. The E. coil tyrosine amber suppressor tRNA, which differs by a single base in the anticodon from its "parental" tRNAtYr (129) , is active in in vivo and in vitro suppression (119) . This shows that the tRNA with a changed anticodon is still recognized by the AA-tRNA synthetase. Chemical modification of pure tRNA species with known sequences also supports this conclusion. Torulopsis tRNAtYr (150) , cyanoethylated only in the pseudouridine residue of the anticodon, could be charged by purified Tyr-tRNA synthetase to the same extent as unmodified tRNA, albeit at a much slower rate. Similar results were obtained in experiments with yeast tRNAla (419) . Treatment of a tRNA91Y with nitrous acid resulted in a change in its coding specificity (60) . The tRNA (modified presumably in the anticodon) could be charged by the GlytRNA synthetase, although at a slower rate (61) .
Modification of a base next to the anticodon [i.e., the isopentenyladenosine (ipA) residue in tRNAser (106) and tRNAtyr (119) ], or the elimination of a base (386) , do not impair the ability of the tRNA to be charged. The tRNA partially or fully lost their ability, however, to participate in protein synthesis, probably because of a different conformation of the anticodon loop. Experiments with isoaccepting E. coil tRNA-r species also support the view that the anticodon need not be the specific recognition site for the AAtRNA synthetase (372) . Two tRNABer species specified by entirely unrelated codons (UCA and AGU) could be charged to the same extent and at the same rate by a purified E. coli Ser-tRNA synthetase preparation. The two tRNA species competed for the Ser-tRNA synthetase, indicating that they were recognized by the same enzyme. In a different kind of experiment, pure yeast tRNAVaI was split by T1-ribonuclease next to I in the anticodon sequence. The separated half-molecules did not possess acceptor activity. The mixture of both halves, however, accepted almost the theoretical amount of valine despite the break in the polynucleotide chain (25) . This shows that the anticodon does not need to be intact for recognition by the AA-tRNA synthetase.
According to a recent hypothesis (345) based on studies of ultraviolet-inactivation of tRNAAla, the three base pairs closest to the acceptor end of a tRNA molecule represent the specific recognition site for the AA-tRNA synthetase. Two sets of experiments, however, cast some doubt on the general validity of this hypothesis. Rat liver tRNA er can be charged by yeast Ser-tRNA synthetase as well as by the homologous enzyme, although the nucleotide sequences in the presumed recognition site differ in two out of three base pairs in rat liver and yeast tRNAser (360) .
Likewise, yeast tRNAfMet with a sequence different from the corresponding E. coli species can be charged by the E. coli Met-tRNA synthetase (313) . However, in both cases, tRNA was charged by heterologous enzymes and, therefore, these results may not serve as a firm basis for invalidating the above hypothesis. The large degree of homology in the structures of the various tRNA makes it difficult to recognize a specific contiguous nucleotide sequence in an identical position in all tRNA as recognition site for the AA-tRNA synthetase. The process may involve the recognition of features of tertiary structure, as has been suggested (77) .
Minor and Redundant tRNA Species E. coil tRNA can be separated into a large number of distinct fractions by chromatographic 270 BACTFMO0L. REV.
techniques (264, 408) . Artifacts of preparation and chromatography resulting in tRNA aggregates (222, 354, 422) and in inactive (118, 217) and partially modified tRNA species may account for some of the fractions. However, there is cause to believe that many fractions are distinct minor tRNA species. In a few cases, these have been shown to be redundant tRNA (multiple isoaccepting tRNA specific for the same codon) (353, 354) . The existence of redundant tRNA may explain certain mechanisms of nonsense or missense suppression (129, 139) . At (86, 198 (172, 370) . More recent studies involving fractionation of Leu-tRNAIeu by reverse phase chromatography provide evidence for the selective inactivation of the major tRNAIeU species (399, 400) and may support the notion (400) that this is due to the action of a phage-induced nuclease specific for this species. Concomitant with the inactivation of the major tRNALeu is the appearance of new, possibly phage-coded, tRNAI'U species, as revealed by reverse phase chromatography (170, 172) . Binding studies with fractions of Leu-tRNALeu from infected and uninfected cells were not completely successful in elucidating the coding response of the various tRNAIAU species (171) .
Phage-coded tRNA. The studies of cysteinedependent thiolation of tRNA (163) provided another tool for testing tRNA after phage infection. In uninfected and phage-infected cells grown on IS-sodium sulfate, all sulfur-containing RNA proved to be 4S RNA, the elution profiles of which on MAK columns were different for tRNA from infected and uninfected cells (163) . The material of the major new peak from infected cells does not hybridize with E. coli DNA, but it hybridizes with T4 DNA; T4 mRNA and E. coli tRNA do not compete in this reaction (407) . Using the elegant technique of hybridizing charged tRNA at low temperature, it was shown that at least one species of tRNAIeU and of tRNAPro was coded by T2 phage (407) .
Only sulfur-containing tRNA species can be detected by the above method. The failure to observe gross tRNA changes in cells infected with T-odd, MS2, or OX 174 phages, therefore, does not exclude the possibility that tRNA species are coded by these phages.
Herpes simplex virus was shown to specify at least one species of tRNA rg (367, 368) . The multiplication of the oncogenic BS1 virus was reported to be associated with the appearance of virus-specific tRNA (391) .
Cytokinins and tRNA The cytokinins are substances which promote cell division, growth, and organ formation in plants. Their activity is usually measured by the increase caused in the cell mass of tobacco stem (151) . Of all the cellular components, tRNA is uniquely associated with cytokinin activity. Such activity was found in the tRNA of bacteria, plants, and mammals.
Since the discovery of ipA, a very potent cytokinin, as a'constituent of yeast tRNA (31, 145) , many examples of cytokinin-active nucleotides in crude and purified tRNA preparations have been reported (119, 144, 147, 231, 324, 348, 360, 379, 423) . For instance, the derivative of ipA, N6-(cis-4-hydroxy-3-methyl-but-2-enyl) adenosine, occurs in the tRNA of plant tissues (144) (119) . Whether these effects on coding properties play a role in the mechanism of action of the cytokinins remains to be determined. Treatment of tRNA with KMnO4 converts ipA residues to A residues; tRNA treated with KMnO4 was added to rat liver or yeast extract supplemented with labeled mevalonate or isopentenylpyrophosphate. It was established that in the extract isopentenyl side chains became linked to A residues of the treated tRNA. This linkage is catalyzed by an enzyme which is specific for certain A residues in selected tRNA molecules (107, 185) .
Cell Wall Synthesis and tRNA A novel role for tRNA has recently been discovered: it participates in the synthesis of bacterial cell walls and aminoacylphosphatidylglycerols, compounds found in certain bacteria. In in vitro experiments with four different bacterial strains, a strict requirement has been shown for tRNA in the biosynthesis of the pentapeptide bridges linking the peptidoglycan strands of bacterial cell walls (49, 242, 308, 322, 323) . Gly-tRNA in Staphylococcus aureus (49, 242) , Thr-tRNA in Micrococcus roseus (323) , Ser-and Gly-tRNA in S. epidermidis (308) , and I Ala-tRNA in Arthrobacter crystallopoietes (322) 4 transfer their respective amino acids into the I bridge. This reaction is catalyzed by a particulate i enzyme fraction. The process is specific for the amino acid. Heterologous tRNA can replace the homologous tRNA in certain cases (242, 308, 322, 323) . The substrate specificity of the enzyme for the tRNA was demonstrated in the following experiment: Ala-tRNACYs [prepared by desulfurization with Raney nickel from Cys-tRNAcy0 (67)] did not substitute for Ala-tRNAAla in the bridge peptide formation as catalyzed by the enzyme fraction from A. crystallopoietes (322) . The role of tRNA was further clarified by fractionation of crude tRNA. Gly-tRNA, SertRNA, and Thr-tRNA obtained from S. aureus, S. epidermidis, and M. roseus, respectively, were fractionated into a number of isoaccepting tRNA species with different coding properties. All these tRNA species participated in in vitro peptide bridge formation. Some of them, however, did not bind to ribosomes in the presence of the corresponding trinucleotide codons and did not support in vitro protein synthesis directed by synthetic and natural messengers. Thus, it seems unlikely that the anticodon is involved in the tRNA specificity.
Studies with a purified Gly-tRNA synthetase from S. aureus have indicated that the same enzyme charges tRNA for protein synthesis and for peptidoglycan synthesis (283) . The mechanism of tRNA participation in the peptide bridge formation is not clear. The process is distinctly different from protein biosynthesis since it proceeds apparently without ribosomes and in the presence of antibiotics like puromycin or chloramphenicol, which are known to block protein synthesis. The synthesis of lysylphosphatidylglycerol in S. aureus requires Lys-tRNA, and also proceeds with heterologous tRNA (215) . The high specificity of the aminoacylphosphatidylglycerol synthetases for tRNA and also for the amino acid has been shown in experiments with a series of chemically or enzymatically produced "mischarged" tRNA species (134, 276) which all possessed acceptor activity after modification. Thus, in the synthesis of alanylphosphatidylglycerol in extracts of Clostridium welchii, N acetyl-Ala-tRNAAla, lactyl-tRNAAla, Ala. tRNACYS, Cys-tRNAcy0, and Phe-tRNAAla could not substitute for Ala-tRNAAL (134).
Differentiated Cells and tRNA
Transfer RNA has been found in mitochondria isolated from yeast (412) , Neurospora (23), Tetrahymena (373) , and rat liver (48, 216 (237) . Another reaction is the conversion of glutamic acid attached to tRNA to glutamine in B. megatherium (410) . A still uncharacterized enzyme catalyzes the formation of Glu-tRNAGIn, which is converted subsequently to Gln-tRNA1ln by a transamidase in the presence of an amide donor. The significance of this reaction is not known. The cyclization of the glutamine residue of E. coli Gln-tRNAGln to pyrrolidone carboxylate-tRNAGln by an enzyme from papaya latex has been reported recently (30) . The enzyme displays no specificity for tRNA since it also cyclizes N-terminal Gln-residues of peptides.
RIBOSOMES
Ribosomes are large ribonucleoprotein particles on which the actual process of translation takes place. There are two functionally different subunits of E. coli ribosomes, the 30S and the 50S subunits. The 30S subunit consists of about 20 different proteins and one species of RNA (165) , whereas the 50S subunit contains about 30 different proteins (G. R. Craven and C. Kurland, unpublished data) and two species of RNA (5S and 23S). Heavy subunits of mammalian ribosomes have been reported to contain an additional RNA species (110, 304) . The most dramatic progress in this field during the past 2 years has been the physical and chemical characterization of the components of E. coli ribosomes and the in vitro reconstitution of active ribosomes from separated nucleic acid and protein components. This discussion is restricted to the above subjects. Other aspects of the formation and structure of bacterial ribosomes have been summarized recently (298) . The biosynthesis of ribosomes in animal cells has been discussed in a recent review (82 (79) .
The acrylamide gel electrophoretic patterns of the proteins from 30S subunits of E. coli strain K-12 and strain B differ in the position of a single band (205) . The two proteins corresponding to these characteristic bands have similar molecular weights of about 20,000, but the proteins differ in at least 10 amino acid residues (32) .
Studies comparing the ribosomal proteins of procaryotic and eucaryotic organisms are under way (68, 169, 363) .
Ribosomal RNA 5S RNA. 5S RNA can be prepared by phenol extraction of whole cells (327) or from isolated ribosomes (122) . With the exception of tRNA, it is the smallest RNA, having a chain length of 120 nucleotides and lacking minor bases. The nucleotide sequence of 5S RNA from E. coil (46) and from a human tumor line [KB (111)] has been established, and it is interesting to note that a part of the nucleotide sequence is duplicated in each of the two 5S RNA species. The sedimentation coefficient of 55 RNA varies from 4.4 to 4.7, depending upon salt and Mg++ concentration (36, 122) . Several conformations have been suggested for this polynucleotide (18, 36, 46, 55) . No function is known for the 5S RNA, although there is a recent report (181) according to which its presence stimulates the phage f2 RNA-directed protein synthesis in vitro.
16S and 23S RNA. Studies on the terminal sequences of 16S and 23S ribosomal RNA have been performed on RNA from a variety of organisms (230) . A heterogeneity in the 3' terminal nucleotide of the 23S ribosomal RNA has been reported. Ribosomal RNA contain small amounts of methylated bases, and the sequences around these minor bases have been examined (108) . The methylation occurs only at a small number of sites. The sequences in the neighborhood of methylated nucleotides occur twice in each 23S RNA molecule.
Reconstitution of Active Ribosomes from RNA
and Protein In solutions of high ionic strength, 30S and SOS ribosomal subunits dissociate into smaller ribonucleoprotein particles (core particles) and proteins. By combining these components in properly selected conditions, ribosomes active in in vitro protein synthesis were reconstituted several years ago (287, 359) . Recently, 23S core particles from the 30S subunit have been dissociated into free 16S RNA and proteins. The separated RNA and core proteins were mixed at 37C, cooled to 4C, and the additional protein fractions from the 30S subunit were added (390 (288) .
The availability of techniques for separating all the ribosomal proteins has opened the way for elucidating the function of the individual proteins. In reconstitution experiments with isolated proteins and RNA from streptomycin-resistant, streptomycin-dependent, and streptomycin-sensitive 30S subunits, a particular protein (of molecular weight 14,000) was shown to be the target of streptomycin action; 30S subunits were reconstituted from the 16S RNA and a mixture of proteins lacking the streptomycin target protein. To the incomplete particles obtained, streptomycin target protein was added, which was obtained from either streptomycin-resistant (299) , streptomycin-sensitive (299) , or streptomycin-dependent (C. Kurland, unpublished data) ribosomes. The behavior of the reconstituted 305 subunit toward streptomycin was determined by the origin of the streptomycin target protein used in this experiment.
PEPTIDE CHAIN INITIATION Much of our knowledge about initiation has come from studies on E. coli and a few other microorganisms. The components known to be involved in this process include an initiator tRNA (fMet-tRNAF) responding to initiator codons, several initiation factors, ribosomal subunits, and GTP.
About 40% of the E. coli proteins have methionine as the N-terminal amino acids, although methionine constitutes only 2.5% of the total amino acid in proteins. Methionine, alanine, serine, and threonine together account for about 95 % of the N-terminal amino acids in these proteins (398) . Over 60% of the Met residues attached to E. coil tRNA have their a-amino group formylated. No other N-formylated AAtRNA has been detected. The formylation of the a-amino group of methionine occurs after the amino acid has been esterified by tRNA; N-formylmethionine itself does not become linked to tRNA (239) . The formyl donor is N'0-formyltetrahydrofolate (2, 84, 237) . The formylating enzyme, Met-tRNA transformylase, has been purified from E. coli (84) .
There are at least two classes of methionineaccepting tRNA species in E. coli; tRNAF and tRNAM. Met-tRNAF can be formylated enzymatically, whereas Met-tRNAM cannot (70, 71) . The tRNAF exhibits unusual base pairing near the 3' and 5' ends (89) . This uniquely distinguishes it from all other tRNA of known sequence (cf. Sequence of tRNA).
Initiator of Peptide Chains: fMet-tRNA The RNA of bacteriophage f2 and R17 can serve as mRNA and, as such, direct the synthesis of at least three virus-specific proteins in the cell-free amino acid-incorporating system from E. coil (59, 272) . Each of these proteins formed in vitro have N-formylmethionine as the N-terminal amino acid (2, 221, 394, 402 (96, 188) .
The following result indicates that fMet-tRNA is the major, if not the only, peptide chain initiator in E. coli. In a cell-free extract of E. coli in which protein synthesis was directed by endogenous mRNA, one fMet residue was incorporated for approximately 150 amino acids, and formylmethionine was the only formyl-amino acid (56) .
Fate of the Formyl and the fMet Residues
As stated earlier, the majority of E. coli proteins have methionine, alanine, serine, or threonine as the N-terminal amino acid. On the other hand, most, if not all, of the E. coli proteins are initiated by N-formylmethionine. This suggests that E. coil (and presumably other bacteria) have an enzyme or enzymes which remove the formyl and in certain cases also the Met residue from the N-terminal end of the peptide chain. Extracts from certain microorganisms [E. coli, B. stearothermophilus, and B. subtilis (1, 115, 378) ] were found to contain enzymes cleaving fMet-peptides into formate and Met-peptides. A protein fraction from E. coil which contained such a peptide deformylase was found to liberate formate from proteins synthesized in vitro. The rate of hydrolysis of fMet-peptides by this protein fraction was greater than that of other formyl-peptides, acetyl-Met-alanine or N-formylmethionine. Such characteristics are those expected from an enzyme whose physiological function is to remove formyl residues from nascent protein (1). The fMet-phetRNA is a substrate for the deformylase, whereas fMet-tRNA is not. This suggests that the deformylation may occur soon after the incorporation of the fMet residue into a fMet-AA-tRNA intermediate (220) . The peptide deformylase of E. coli is very labile in vitro and is inhibited strongly by compounds with sulphydryl groups. The proteins synthesized in vitro retain their formyl residue presumably because the deformylase does not survive the procedures used in preparing and testing the cell-free extract (1) .
Since the peptide deformylase removes only formyl residues, it is expected that other enzymes are responsible for removing the Met residues. Extracts from E. coil and B. subtilis contain an aminopeptidase capable of removing a Met residue from Met-puromycin (but not from fMetpuromycin), and from the N-terminal hexapeptide of f2 coat protein (but only after the formyl residue has been cleaved off by treatment with the deformylase). These observations indicate that if a fMet residue is removed from a nascent protein, this takes place in two steps: first, the formyl residue is cleaved off, and subsequently, the Met residue (378).
E. coli extracts can also cleave N-formylmethionine (409) . This cleavage is believed to be due to acetylornithine deacetylase action. In the extract of an E. coli mutant lacking acetylornithine deacetylase, the rate of hydrolysis of N-formylmethionine was only 1% of that observed in the extract of wild-type E. coli (115) .
The amino acid adjacent to fMet is not unique in the proteins isolated from an E. coli extract in which protein synthesis was directed by endogenous mRNA. Alanine, serine, and, to a smaller extent, other amino acids were found in the position adjacent to the N-terminal residue of the peptide chain (56) .
It remains to be seen if the amino acid adjacent to the fMet residue determines whether the Met residue is removed by the aminopeptidase or if other factors (e.g., the secondary structure of the protein) are decisive. Coding Specificity and Functions of tRNAF and tRNAM One of the methods used in deciphering the code was based on the fact that particular ribotrinucleotides or ribopolynucleotides promote the binding of different AA-tRNA to ribosomes. This binding can be conveniently tested since free AA-tRNAs are not held on nitrocellulose membrane filters, whereas those whose binding to ribosomes is promoted by the proper codon are retained [the so called "binding assay" (278)]. The binding assay and the promotion of amino acid incorporation by mRNA of defined sequence were the techniques used in studies with cell-free systems on the coding specificities and functions of the two methionine-accepting tRNA species. It was concluded that, whereas fMet-tRNA serves as a source of N-terminal Met residues, MettRNAm provides Met residues for internal and C-terminal positions of the polypeptide chains (71, 124, 331) . The codons specifying tRNA] are AUG and GUG; the codon specifying tRNAm is AUG (71, 124, 331, 371 (371, 385) .
The in vitro translation of synthetic messengers not having an AUG codon at or near the 5' end apparently starts mostly at the second triplet (351) . Messengers with AUG at the 5' end, however, are translated from the 5' end (361) . Since neither AUG nor GUG is part of the sequence of the first 10 nucleotides in the RNA of an RNA bacteriophage (83) , it may be presumed that a signal (perhaps AUG or GUG) is present in the phage RNA for initiating the translation at a proper site in the correct reading frame. In polygenic mRNA, such signals must occur at several sites.
Translation of Polygenic mRNA The structural genes for the 10 enzymes of histidine biosynthesis, constituting the histidine operon, are adjacent to each other on the Salmonella typhimurium chromosome. The operon is transcribed into a single polygenic mRNA. The synthesis of all 10 enzymes can be repressed by histidine. When histidine-requiring mutants are grown on limiting amounts of histidine, the level of each enzyme increases about 25-fold. The rate of synthesis of the individual histidine biosynthetic enzymes was followed in cells which were first grown in a medium with excess histidine and then transferred into a medium in which histidine was limiting (derepression). Two modes of derepression were observed. About 20 min elapsed between the increase in the rate of synthesis of the first and the last enzyme when the level of the formyltetrahydrofolate pool (available for formylation of Met-tRNAF) was low. In these conditions, the order of the increase in the rate of synthesis of the individual enzymes was the same as the order of the corresponding genes on the chromosome [sequential translation (27, 28) ]. Sequential translation of enzymes of the lactose (10, 77, 211) , galactose (249) , and tryptophan (165, 263) operons was also reported (99) . This mode of gene expression presumably reflects translation starting from a single initiation site at the 5' end of the RNA. This may be a consequence of (i) the sequential transcription of the polygenic mRNA starting at the 5' end, (ii) the unavailability of internal initiation sites for ribosome attachment due, for example, to secondary structure of the mRNA, or (iii) the lower efficiency of the internal initiation sites than that of the one near the 5' end; furthermore (iv), it might be that not each peptide chain initiation site is a ribosome attachment site as well, and that signals for ribosome attachment onto mRNA may include longer nucleotide sequences than do the signals for peptide chain initiation.
Remarkably, the increase in the rate of synthesis of all enzymes of histidine biosynthesis apparently occurred simultaneously under conditions in which the level of the formyltetrahydrofolate pool in the cells was high (27, 28) . It has been shown that the histidine operon is transcribed into a single mRNA in conditions of either sequential or simultaneous translation (392) . This observation, and the fact that it was the size of the formyltetrahydrofolate pool (presumably regulating the amount of fMettRNA) which determined whether the mode of translation was sequential or simultaneous, suggests that in this case the cause of the difference between the two modes of translation involves primarily the translation process itself and might, for example, be the consequence of having more efficient initiation sites at the 5' end of the mRNA than in internal positions. Simultaneous initiation of the translation of two different polypeptides was also observed upon adding f2 RNA to the in vitro E. coil system (221) . The simultaneous mode of translation seems to require that ribosomes do attach simultaneously to several sites of the polygenic mRNA. Consequently, a free 5' end of the mRNA may not be a prerequisite for this attachment. In support of this conclusion, it has been shown that a circular messenger (i.e., one with no ends) promotes the binding of fMet-tRNA and amino acid incorporation into polypeptides (39 95, 155) .] The complex containing a 305 subunit and fMet-tRNAF is a compulsory intermediate for initiation, as shown by the following observations. "Heavy" ribosomes (70S) were prepared from E. coli (grown in a D20-and 15N-containing medium) by extracting the cells in conditions in which a large part of the ribosomes sediment as 70S components. These 70S "heavy" ribosomes were included in a reaction mixture containing, among other components, "light" 50S ribosomal subunits, poly (A, U, G), fMet-tRNAF, Val-tRNA, and initiation factors. After analyzing the reaction mixture after incubation by density gradient centrifugation, it was established that the majority of the fMettRNAF was attached to hybrid 70S ribosomes, whereas most of the Val-tRNA was bound to "heavy" 70S ribosomes. These results indicate that 70S ribosomes must dissociate into their subunits preceding fMet-tRNAF binding, although not preceding Val-tRNA binding (141) .
Process of Initiation
Steps in initiation (Fig. 2) . As indicated in the previous section, a complex including fMettRNAF, mRNA, and a 30S subunit [(285); complex I] is apparently one of the early intermediates in peptide chain initiation. The formation of complex I requires GTP and initiation factors (9, 11, 95, 141, 153, 155, 207, 227, 265, 285, 331) . Subsequently, a 50S subunit seems to attach to complex I (complex II). The fMet-tRNAF in complex II is thought to be bound at the hypothetical site A of the ribosome (123, 189, 190, 265, 286, 336) . In the next step, fMet-tRNAF is believed to be translocated to site P, a second hypothetical site on the ribosome (complex III). There are indications that GTP may be cleaved into guanosine diphosphate (GDP) and orthophosphate (P i) in the course of the transformation of complex II to m (187) . The formation of complex III is the last step in chain initiation.
Characteristics of initiation complexes. The fMet-tRNA3 and mRNA bound to ribosomes (e.g., in complexes I, II, and III) may be distinguished from the free species by filtration through nitrocellulose filters; the bound species are retained on the filters, whereas the free species are not (278) . Free fMet-tRNAF, free mRNA, The filtration assay is much faster than the one and complex I can also be separated from each involving ultracentrifugation. This may account other and from complexes II and II by centrifu-for the fact that a loose complex which is disgation through a sucrose gradient.
played as a complex in filtration may dissociate
at least partially into its components in the course of ultracentrifugation (190) . Using these techniques, it was established that the coupling of 30S and 50S subunits to form 70S ribosomes (i.e., complexes II or III) strictly depends at 5 mm Mg++ on mRNA (actually, f2 RNA was used), fMet-tRNAF initiation factors, and GTP (190) .
5'-Guanylyl -methylene -diphosphonate (GMPPCP), an analogue of GTP, can substitute for the latter in the formation of complex I (11, 265) and in the subsequent attachment of the 50S subunit to this complex (189, 190) . GMPPCP has a methylene bridge between the : and y phosphorus atoms and, thus, cannot undergo enzymatic cleavage into GDP and Pi (152) . The fact that it can substitute for GTP indicates that GTP cleavage need not occur before or during the initial attachment of a 50S subunit to complex I. The complex formed in the presence of GMPPCP and the complex formed in the presence of GTP behave similarly in the filtration test. However, the complex formed in the presence of GMPPCP largely dissociates in the course of centrifugation through a sucrose gradient (190) and does not react with puromycin (292), whereas the complex formed in the presence of GTP largely persists in the sucrose gradient test (190) and does react with puromycin, giving rise to fMet-puromycin (42, 206, 292, 331) .
Puromycin and the tRNA binding sites of the ribosome. Puromycin is an inhibitor of protein synthesis which may be considered an analogue of the terminal aminoacyladenosine portion of AAtRNA (417) . Puromycin can react with peptidyltRNA (125) in the presence of ribosomes (262) , giving rise to peptidyl-puromycin and free tRNA (258) . This reaction may serve as a basis for defining different tRNA binding sites on the ribosome (388) .
Polyphe-tRNA, whose synthesis is directed by poly U in the in vitro system, remains bound to the ribosomes (125) . Ribosomes FMet-tRNAF in the initiation complex formed in the presence of GMPPCP (as well as mRNA and initiation factors) does not react with puromycin (292) . This seems to suggest that the initiator tRNA is not bound to site P of the ribosome in these conditions. Furthermore, tetracycline, an antibiotic inhibiting the binding of AA-tRNA to the A site (133) , was found to block the binding of fMet-tRNAF to ribosomes in the presence of GTP, mRNA, and initiation factors (336) . This suggests that fMet-tRNA is bound, at least initially, to site A.
FMet-tRNAF in the initiation complex formed in the presence of GTP (as well as mRNA and initiation factors) does react with puromycin (42, 206, 292, 331) . This reveals that in these conditions fMet-tRNAF is bound to the P site [(388), complex III].
The above results, and the fact that the guanosine triphosphatase activity of an initiation factor (F2) is stimulated by fMet-tRNAF, 30S and 50S subunits, mRNA, and other initiation factors, are consistent with, although they do not necessarily prove, the following sequence of events. FMettRNAF is attached to the A site first (complex II) and is subsequently translocated to the P site (complex III). GTP is cleaved before or during this translocation (187) .
Role of initiation factors. Several complementary initiation factors have been isolated from crude preparations (45, 187, 232, 291, 301, 320) . The relation of all the factors described by the various investigators remains to be established. The highest number of complementary factors reported from a single laboratory is four; some of these appear to consist of several nonidentical subunits (291) .
At least some of the initiation factors can be found attached to native 30S subunits (95, 301) . The same factors do not occur on either 70S ribosomes or free 50S subunits (301) . This suggests that the factors are released from the 30S subunits sometime after the 50S subunit becomes attached to the 30S subunit in the course of initiation. Since initiation factors were not found in the high-speed supernatant fraction of the cell extract, it may be assumed that they are present in short supply, and as soon as they are released from 70S ribosomes they become bound to 30S subunits.
The order in which the components of complex I are associated is not known. The data available are in line with, but do not prove, the view that the binding of a 30S subunit to mRNA occurs first and is followed by the attachment of fMettRNAF (12, 45) . Apparently, one or two factors (in addition to GTP) are involved in the attach-ment of mRNA to the 30S subunit (45, 187, 291, 320) .
It remains to be seen whether the positioning of a ribosome on an initiation sequence of the mRNA is assisted by fMet-tRNAr or by initiation factors. It was reported that some of the initiation factors are needed for the translation of certain natural messengers, but not for that of synthetic messengers with AUG or GUG at or near the 5' end (291, 320) . This raises the interesting possibility that the factors may recognize an initiation sequence longer than AUG or GUG. If such longer initiation sequences exist, they may serve as a basis for explaining the postulated occurrence of initiation sequences with different efficiencies (241) .
There is no agreement between reports concerning, for example, the following problems (291, 320) . Is the binding of mRNA and of fMet-tRNAF to the 30S subunit mediated by the same initiation factor or by different ones? Is the attachment of the SOS subunit to complex I promoted by a factor also needed in forming complex I? It may be expected that with the availability of pure factors, these and other apparent discrepancies will be resolved.
Role of the formyl residue and of tRNAF in initiation. The following observations indicate that unformylated Met-tRNAF cannot initiate protein synthesis in E. coli. Met-tRNAF does not substitute for fMet-tRNAF in allowing translation of f2 RNA in vitro at low Mg++ concentration (96, 188) . Protein synthesis in vivo stops if the formylation of Met-tRNAF is inhibited (343) . These results may be the immediate consequence of the fact that the initiation factors which promote the binding of fMet-tRNAF to ribosomes in the presence of GTP and initiator triplets do not promote the binding of unformylated Met-tRNAF (332) . The ultimate basis for blocking the a-amino group of the initiator tRNA is, however, presumably the substrate specificity of the enzyme catalyzing peptide bond formation (257 (227) . This result and the fact that initiation factors do not recognize unformylated Met-tRNAF as their substrate indicate that the factors or the components with which they interact recognize whether the a-amino group is blocked or not. Transfer RNAF and its derivatives are distinguished from other tRNA and their derivatives by the following enzymes: (i) the transformylase which formylates Met-tRNAF, but not MettRNAM (84, 237) ; (ii) the initiation factors and the 30S ribosomal subunit which appear to form a more stable complex with fMet-tRNAF than with acetyl-Phe-tRNA (138); (iii) factors involved in peptide chain elongation which do not recognize fMet-tRNAF or Met-tRNAF as their substrate (295); (iv) an enzyme hydrolyzing N-acyl-AA-tRNAs (81), which hydrolyzes fMet-tRNAM (to N-formylmethionine and tRNAM) but does not attack fMet-tRNAF or acetyl-Met-tRNAp (192, 395) . This enzyme also hydrolyzes peptidyltRNA [at least one with a blocked a-amino residue (192) ]. A possible function of this hydrolase is to destroy analogues of fMet-tRNAp and to thus avoid false chain initiation. (84) suggest, but do not prove, the involvement of fMet-tRNA in protein synthesis in these organisms.
Eucaryotic cells. N-formylmethionine was reported as the N-terminal residue of the viral coat protein synthesized in a system containing Eglena gracilis chloroplast ribosomes, E. gracilis high-speed supernatant fraction, and f2 bacteriophage RNA (338) . FMet-tRNA has also been found in mitochondria from yeast and rat liver (350) . Protein synthesis in chloroplasts and mitochondria resembles that in bacteria in several ways. Thus, chloramphenicol and some other antibiotics inhibit chloroplast (93, 240, 303) and mitochondrial protein synthesis in vivo and in vitro (73, 193, 318 ), but do not seem to affect the cytoplasmic system from yeast and rat liver. Similarity among ribosomes from chloroplasts, mitochondria, and bacteria is suggested by the finding that all these particles have a sedimentation coefficient of about 70S, whereas that of the ribosomes from the cytoplasm is about 80S (34, 72, 194, 228, 365, 383) . The existence of fMettRNA in mitochondrial, chloroplast, and bacterial systems may indicate that the same initiator is characteristic of 70S ribosomes in general.
FMet-tRNA has not been detected in the cytoplasmic system, and the initiator serving 80S ribosomes is not known.
Pyrrolidone-2-carboxylic acid has been shown to be an N-terminal residue in several proteins (311) . It is an intriguing possibility that pyrrolidone-2-carboxylic acid may arise by the cyclization of a specific Gln-tRNA, which in turn serves as an initiator (30, 255) . In view of the easy cyclization of glutamine to pyrrolidone-2-carboxylic acid, careful studies will be needed to examine this possibility. A number of proteins have N-acetylated amino acids as the N-terminal
residue. An enzyme has been isolated from chicken reticulocytes catalyzing the transfer of the acetyl residue from acetyl-coenzyme A to certain proteins. This finding indicates that masking of the a-amino group of the N-terminal amino acid may occur after protein synthesis (236) .
PEPTIDE CHAIN ELONGATION
Studies on peptide chain elongation in microbial extracts were greatly facilitated by the fact that at relatively high (presumably unphysiological) Mg++ concentration incorporation of aminoacyl residues from AA-tRNA into polypeptidyltRNA can be directed by natural or synthetic messengers (even if the latter lack initiator codons), and does not require either fMet-tRNAF or initiation factors (96, 213, 218 (218, 267 ; see Role of the formyl residue and of tRNAF in initiation).
A simple system convenient for experiments on elongation is one in which the synthesis of a homopolypeptidyl-tRNA (e.g., polyphe-tRNA) is directed by a homopolyribonucleotide [e.g., poly U (279) ]. In addition to the mRNA, AAtRNA, proper ions, and thiols, such systems need to include ribosomes, GTP (176) , and components of the high-speed supernatant fraction of the cell extract (271) . To observe a strict dependence of amino acid incorporation on the high-speed supernatant fraction, the ribosomes have to be thoroughly washed. This treatment apparently removes from the ribosomes (among other substances) the factors required in elongation (271) .
It should be noted that the large majority of elongation factor activity is in the high-speed supernatant fraction of microbial extracts (271) . This is in marked contrast with the initiation factor activity which, as stated earlier, is exclusively located in the pellet obtained by centrifuging the extract at high speed.
Elongation Factors Elongation factors were purified from the highspeed supernatant fraction of the extract of a number of bacteria and from yeast. Initially, two factors were found to be required for polyphetRNA synthesis in E. coli extract, factor T and factor G (7). These two factors were also obtained in crystalline form (175, 302) . More recently, the T factors from E. coli and from P. fluorescens have been divided into two active components, both of which are needed (together with factor G) in polyphe-tRNA synthesis; one component is unstable (Tu), the other is stable (T8 ; 226) . Separated Tu and T8 form a complex with each other. In the presence of GTP, this complex apparently dissociates into a Tu-GTP complex and T8 (103, 250) .
Three elongation factors (Si, S2, and S3) were purified from the extract of a thermophilic organism, B. stearothermophilus. Si apparently corresponds to T8, S2 to G, and S3 to Tu . All three partially purified B. stearothermophilus elongation factors are stable (349) .
Elongation factors were prepared from E. coli extract also in the presence of phenylmethylsulfonylfluoride, an inhibitor of proteolysis. In these conditions, two elongation factors were isolated, both of which are required in polyphe-tRNA synthesis: factor E and a heat-stable protein. The exact relationship of these two factors to factors T and G is not known. It seems, however, that factor E contains some components of both factors T and G (161) . Two elongation factors were obtained from the high-speed supernatant fraction of an E. coli extract which was treated with pHMB, a compound known to react with SH groups. One of the two factors is a protein which retains its activity even after boiling in acid. The factor is apparently not identical with either Tu X T8, or G (421) .
The variety of complementary elongation factors obtained from E. coli extracts treated in different ways may indicate that these factors are in a complex unit in vivo which can be artificially divided into sets of components in several ways. This possibility and the fact that a thorough and lengthy washing of the ribosomes is required in order to remove from them all of the elongation factor activity should admonish us to caution in interpreting the results obtained in the in vitro system. It may well be that the artificially disrupted system in which elongation is studied in vitro does not reflect faithfully the functioning of the elongation machinery in vivo. Complementary elongation factors were also isolated from yeast extract (19, 321) .
Process of Elongation
Outline of the steps in elongation. A hypothetical scheme of steps in chain elongation is shown in Fig. 3 . This scheme is based mainly on experiments with the Tu, T., and G factors from E.
coli and the Si, S2, and S3 factors from B. stearothermophilus. (Subsequently, whenever possible, the Si, S2, S3 nomenclature will be used.)
The last step in peptide chain initiation is apparently the translocation of fMet-tRNAF from site A to site P on the 70S ribosome-mRNA complex (cf. Steps in initiation). The first composite step in the next phase (i.e., peptide chain elongation) is presumably the attachment (to the vacant A site in complex III) of AA-tRNA specified by the codon adjacent to the 3' side of the initiator codon [AA-tRNA binding (168, 266, 278) ]. The product of this step will be designated as complex IV. The attachment of AA-tRNA to complex III (which leads to the formation of complex IV) requires GTP and involves the factors S3 and Si (102, 224, 314, 349) . Results of in vitro experiments seem to indicate that GTP is cleaved to GDP and Pi in this step (296, 344) .
Subsequently, the carboxyl group of the formylmethionyl residue of the fMet-tRNAF is released from its linkage to tRNAF and is linked in a peptide bond with the a-amino group of the AA-tRNA (peptide bond formation). In the product of this step (complex V), the fMet-AAtRNA is located at site A (100, 101, 142) . Peptidyl transferase, the enzyme catalyzing this reaction, apparently is part of the 50S subunit (256) .
In the course of the next composite step (translocation), the following events are presumed to occur: (i) the discharged tRNA (in site P) is released from the ribosome, (ii) the fMet-AAtRNA is shifted from site A to site P, and (iii) the ribosome moves the length of one codon along the mRNA in the 5'-to-3' direction (401) . Translocation is catalyzed by an elongation factor (S2). When studied in vitro the step also requires GTP which is cleaved to GDP and Pi (44, 100, 101, 142, 306, 381) .
Thus, both AA-tRNA binding and translocation require the cleavage of GTP when studied in vitro. It remains to be seen, however, whether in vivo the cleavage of two GTP molecules is needed for the two steps or if cleavage of one GTP suffices.
After translocation, the stage is set for the addition of another amino-acyl residue to the fMet-AA-tRNA. Each addition requires the following cycle of events: AA-tRNA binding, peptide bond formation, and translocation. These events will be discussed in more detail in subsequent sections.
In the second cycle and in all the subsequent ones, peptidyl-tRNAs are taking the place of fMet-tRNA. The cycles are repeated and the peptide chain is growing, presumably until a terminator codon in mRNA is reached by the A site of the ribosome.
AA-tRNA Binding
The need for GTP and a factor (from the high-speed supernatant fraction of the cell extract) in attaching AA-tRNA to the mRNAribosome complex was first established in a cellfree system from reticulocytes (15) . The requirement for GTP and a factor in catalyzing the same step in microbial systems was not revealed for quite a while. This delay was a consequence of the following facts. Chain elongation was studied mainly with poly U, which promotes polyphe-tRNA synthesis only at high Mg++ concentration. At high Mg+ concentration, in turn, there is a strong AA-tRNA binding which is independent of factors and GTP, and which may obscure the factor-and GTP-dependent binding (197, 314) .
Recent binding experiments in the E. coli system (314) and the yeast system (19, 321) were performed, however, at lower Mg+ concentrations; under such conditions there is a need for GTP and supernatant factors in binding phetRNA to the ribosome-poly U complex (314) . Apparently, two factors (Si and S3) are involved in this step (102, 142, 349) .
The following events are presumed to precede the binding of AA-tRNA to the ribosome. First, Si and S3 form a complex with GTP (complex A). Complex A can be assayed conveniently since it is retained on nitrocellulose filters (8, 132, 315) . The complex can be separated from free GTP by gel filtration (8, 349) . Both Si and S3 are required in complex A formation (102, 349) ; apparently the amount of S3 determines the quantity of GTP bound, whereas the amount of Si determines the rate of complex formation (103) . S3 is present in complex A, but it has not been definitely established whether SI is also part of the complex. ATP is not bound by Si and S3, whereas GDP is.
In a subsequent step, complex A apparently binds AA-tRNA and is transformed into a GTP-AA-tRNA-S3 complex (complex B) (132, 349) . The formation of complex B from its components requires Si (349) . There are indications that SI may not be part of complex B (316) . This complex, in contrast to complex A, is not retained on nitrocellulose filters (132, 315) . It can be separated from unbound GTP and AA-tRNA by gel filtration (349) . The ratio of GTP and AA-tRNA in complex B is approximately 1:1 (131, 295) . Binding of AA-tRNA in the complex depends strictly on GTP. GTP cleavage was not observed in the course of the formation of complexes A and B (131, 349) . Most, and probably all, AA-tRNA species do form the complex (295) . (For an important exception, see Problems Arising from the Dual Specificities of the AUG and GUG Codons.) The existence of competition between different AA-tRNA in binding indicates that the same S3 factor can bind different AA-tRNA species (295) . Uncharged tRNAs is not bound in the complex and an excess of uncharged tRNA does not compete with AA-tRNA for binding (131, 295, 349) . GDP and ATP do not substitute for GTP in making the binding of AA-tRNA possible (349) .
There are indications that the GTP molecule in complex B is cleaved to GDP and Pi after the binding of phe-tRNA to the poly U-ribosome complex, but before peptide bond formation (296, 344) . According to one report (296) , the same partially purified SI and S3 fractions from B. stearothermophilus which promote the binding of AA-tRNA to ribosomes also catalyze the cleavage of GTP to GDP and Pi in the presence of ribosomes. This cleavage is promoted by the simultaneous presence of poly U and phe-tRNA. The ratio of GTP cleaved to phe-tRNA bound is approximately 1. Since it is known that in the presence of ribosomes the factor S2 also catalyzes the cleavage of GTP, it was ascertained that the GTP cleavage promoted by partially purified Si and S3 is not due to S2 contaminating these factors; it was shown that fusidic acid, an antibiotic inhibiting the guanosine triphosphatase activity of S2, has no effect on the GTP cleavage catalyzed by Si and S3 (296) .
In another study (344) , partially purified Si and S3 factors from E. coli were used to form complex B with GTP and phe-tRNA. This complex was added to a reaction mixture containing poly U and ribosomes. Upon incubating this mixture, phe-tRNA became bound to ribosomes and about an equimolar amount of GTP was cleaved to GDP and P i. The resulting GDP was found in a complex with S3 .
The following facts are consistent with the hypothesis that GTP cleavage occurs after the binding of AA-tRNA to the mRNA-ribosome complex but that it precedes the next step of chain elongation, i.e., peptide bond formation. (i) If GMPPCP (the analogue of GTP which cannot be cleaved enzymatically to GDP and P i) is substituted for GTP, phe-tRNA is bound to the ribosome-poly U complex in the presence of SI and S3 but peptide bond formation does not take place, whereas in the presence of GTP it does (142, 296; see also 347). (ii) Sparsomycin, an antibiotic which blocks peptide bond formation (128, 260) , does not inhibit either AA-tRNA binding (224, 296) or GTP cleavage catalyzed by the factors Si and S3 (296) .
It might have been expected that a compound such as tetracycline, which inhibits the binding of AA-tRNA to the mRNA-ribosome complex (133, of the guanosine triphosphatase activity (of Si and Sa in the presence of ribosomes) by poly U and phe-tRNA. Somewhat unexpectedly, it was found that tetracycline had no effect on the GTP cleavage (296) . It remains to be seen whether this lack of inhibition is indicative of the existence of a loose binding of AA-tRNA to the ribosome which may occur in the presence of tetracycline and which is sufficient to promote the guanosine triphosphatase activity of Si and S3 .
S3 may be recovered bound to the ribosomes if incubated in a reaction mixture including poly U, phe-tRNA, Si, and GMPPCP. If, however, GTP is substituted for GMPPCP, Ss cannot be found attached to ribosomes. These observations are consistent with the possibility that Ss may become attached to the mRNA-ribosome complex together with GTP and AA-tRNA and is released from the complex after the GTP has been cleaved but prior to peptide bond formation. Since GMPPCP is not cleaved, S3 remains attached (A. Skoultchi, Y. Ono, and P. Lengyel, in preparation).
GTP cleavage in the course of AA-tRNA binding to the mRNA-ribosome complex was first reported long ago by Schweet and his collaborators in experiments on the reticulocyte system (15; see also 245).
Peptide Bond Formation After the attachment of AA-tRNA to the fMet-tRNAF-ribosome-mRNA complex in the first cycle of chain elongation (or to a peptidyltRNA-ribosome-mRNA complex in all subsequent cycles), the stage is set for peptide bond formation (Fig. 3) . The peptide bond is formed between the carboxyl group of the fMet-tRNAp (or of the carboxy terminal aminoacyl-residue of the peptidyl-tRNA) and the a-amino group of the AA-tRNA.
Some of the characteristics of the peptide bondforming reaction are the following. Supernatant proteins and GTP are probably not directly involved (229, 256, 305, 388) . Peptidyl transferase, the hypothetical enzyme thought to catalyze it, is apparently an integral part of the 50S subunit (229, 256, 258, 388) . The presence of di-and monovalent cations (Mg++ and K+ or NH4+) is required for the reaction (259, 388) . CpCpA, the 3' terminal nucleotide sequence common to all species of tRNA, seems to be involved in the interaction with peptidyl transferase of both the peptidyl-tRNA (in site P; 257) and the AA-tRNA (in site A; 330).
Most of these conclusions were derived from studies with substrate analogues which lack certain functional parts of the tRNA molecules but retain others. Puromycin, the most widely used of these, is an analogue of the terminal aminoacyladenosine moiety of the AA-tRNA. It contains that part of the tRNA which participates in peptidyl transfer, but lacks those parts which are involved in the codon specific binding to mRNA and binding to ribosomes. The peptidyl moiety of peptidyl-tRNA can be linked in a peptide bond to puromycin instead of to AA-tRNA. The resulting peptidyl-puromycin is released from the ribosomes (3, 125,258,262,270,417) . Polyphe-tRNA, the synthesis of which in vitro is directed by poly U, remains attached to ribosomes (125) . Ribosomes, with attached polyphe-tRNA, retain the ability to react with puromycin after having been washed with salt solutions under conditions similar to those which make ribosomes dependent upon the elongation factors and GTP for polypeptide synthesis (229) . This suggests that the elongation factors and GTP are not directly involved in peptide bond formation. This conclusion is reinforced in studies with ribosomes isolated free of mRNA and peptidyl-tRNA. Such ribosomes, even after thorough washing with salt solution, are still able to catalyze the reaction of puromycin with polylysyl-tRNA (in the presence of poly A; 329) or with fMet-tRNA (in the presence of, for example, the AUG triplet; 42, 424) .
Lowering the Mg++ concentration of a solution containing ribosomes with poly U and polyphetRNA attached causes dissociation of the complex into 30S subunits and 50S subunits with bound polyphe-tRNA (125) . The fact that such charged 50S subunits can react with puromycin indicates that peptidyl-transferase, the enzyme catalyzing the reaction, is located in the 50S subunit (388) . This conclusion is supported by experiments in which isolated, washed 50S subunits were found to catalyze the reaction of puromycin with CAACCA-fMet, a 3' terminal fragment of fMettRNAF (256) . The reaction of puromycin with this fragment evidently takes place by the same mechanism as peptide bond formation in protein synthesis, since both reactions require the same mono-and divalent cations and the fragment reaction is inhibited by certain antibiotics [e.g., chloramphenicol, gougerotin, and sparsomycin (406) ] known to inhibit in vivo and in vitro protein biosynthesis (128, 256) .
The fragment reaction requires the presence of alcohol (e.g., ethyl alcohol) for reasons not known at the present time (259) .
The substrate specificity at the P site was studied by comparing the activity of various analogues of peptidyl-tRNA in the puromycin reaction (257) . Various AA-oligonucleotides and acyl-AA-oligonucleotides were isolated from par-tial nuclease digests of AA-tRNA or acyl-AAtRNA. It was observed that the donor must have a CCA nucleotide sequence for the puromycin reaction to take place: e.g., CCA-fMet and CCAacLeu are active as peptidyl donors, whereas CA-fMet andA-fMet areinactive. The nucleotides in the next three positions seem to affect the reaction only slightly, since the activity of CCAfMet is about the same as that of CAACCA-fMet. Acyl-AA-tRNAs (e.g., acLeu-tRNA) are more active than the corresponding fragments (e.g., CCA-acLeu), suggesting that other moieties of the tRNA molecule besides the terminal CCA interact with the 50S subunit (257) .
The substrate specificity at the A site was examined by comparing the activity of various AA-tRNA analogues as peptidyl acceptors. The role of the 3' terminal nucleotide grouping in peptidyl acceptor substrates is indicated by the following results. Polylys-tRNA is released from ribosomes and the bond between the polylysyl residue and tRNA is cleaved by CpA-Gly (forming, presumably, CpA-Gly-(Lys)n), whereas UpA-Gly has little releasing activity and UpUGly and pA-Gly have none (330) .
In the peptidyl-tRNA bound at the P site in chain elongation, the a-amino group of the carboxy terminal aminoacyl residue is blocked (by the carboxyl group of the adjacent AA-residue of the peptide chain). Consequently, it is not surprising that AA-tRNA or AA-oligonucleotides with a blocked a-amino group (e.g., acPhe-tRNA or CACCA-acLeu) are much more reactive with puromycin than the corresponding AA-tRNAs or AA-oligonucleotides with a free a-amino group (42, 207, 257) . The requirement (or at least preference) of the peptidyl transferase for a blocked a-amino group in the aminoacyl residue attached to the donor tRNA may be the ultimate cause for having the a-amino group in the chain initiator (fMet-tRNAF) blocked.
Translocation
After peptide bond formation, the newly formed peptidyl-tRNA (fMet-AA-tRNA in the first cycle of chain elongation) is located in site A (100, 101, 142 ; see also 218, 388, 401) , and the discharged tRNA, which remains bound to the ribosome (225), probably in site P (complex V in Fig. 3 ). Translocation (represented schematically by the conversion of complex V to complex VI in Fig. 3 ) is a composite step catalyzed by the S2 factor. Translocation requires GTP, which is apparently cleaved to GDP and Pi (44, 75, 100, 101, 142, 281, 282, 306, 388) . Complex VI is analogous to complex m: the P site is occupied in both by peptidyl-tRNA (actually by fMettRNA in complex IM) and the A site is free.
The results and considerations on which these conclusions are based include the following. The acPhe-tRNA was bound to a ribosome-poly U complex in the absence of initiation and elongation factors [at relatively high Mg++ concentration (142)]. The acPhe-tRNA ribosome-poly U complex was incubated with phe-tRNA, GTP, Si, and Sa, and subsequently the ribosomes with the attached components were isolated from the reaction mixture by centrifugation. It was established (i) that the reisolated ribosomes have acdiPhe-tRNA attached, but no (or little) actriPhe-tRNA. (ActriPhe-tRNA was not found in the supernatant fraction of the incubation mixture, either.); (ii) The large majority of the acdiPhe-tRNA did not react with added puromycin, indicating that it was bound at the A site. (iii) Discharged tRNA was sticking to the ribosomes (225) , probably at the P site. These characteristics suggest that the above complex resembled complex V.
Upon incubating the isolated complex with GTP and S2, the discharged tRNA was released from the ribosomes (225; see also 195, 196, 340, 375) and most of the acdiPhe-tRNA became reactive with added puromycin, indicating that it was now located at the P site (142) . A portion of the complex was reisolated after the incubation with GTP and S2 . After incubating this reisolated complex with Si, S3, Phe-tRNA, and GTE, the formation of actriPhe-tRNA was observed. Thus, the incubation with S2 and GTP made the A site available for binding Phe-tRNA, which in turn made tripeptidyl-tRNA synthesis possible (142) .
In another study, AUGUUU and AUGUUU-UUU were used as mRNA in the E. coli system. The fMet-Phe-tRNA was synthesized in the presence of GTP, initiation factors, Si, and S3 (the last two not resolved from each other) in the presence of either mRNA; the formation of fMet-Phe-Phe-tRNA, however, also required S2 factor and occurred only in the presence of the tricodon mRNA (AUGUUUUUU). The fact that the synthesis of fMet-Phe-Phe-tRNA required a tricodon as the messenger is consistent with the view that translocation involves a movement of the ribosome along the mRNA (100, 101) . These findings indicate that S2 is not needed for dipeptidyl-tRNA formation but that it is required for tripeptidyl-tRNA formation. The data are in accord with the view that the action of S2 results in (i) release of the discharged tRNA, (ii) translocation of the peptidyl-tRNA from the A site to the P site, and (iii) movement of the ribosome along the mRNA the length of one codon (218, 401) . There is no cause to assume that translation of codons beyond the third would require additional factors. The studies cited so far in this section provided some insight into the order of events in tripeptide synthesis and the role of the S, factor in this process. For assaying only S2 activity, however, less-involved procedures are available. Each of these is based on one of the following observations. (i) As stated earlier, S2 factor and GTP increase the fraction of ribosome-bound polyphetRNA which reacts with puromycin (388) . (ii) At relatively high Mg++ concentration, phe-tRNA may be attached to ribosome-poly U complexes in the absence of elongation factors. The fraction of the bound phe-tRNA, which is reactive with added puromycin, is increased several fold by incubating the complex with S2 and GTP (44) . (iii) At relatively high Mg++ concentration in a system including ribosomes, poly U, and phetRNA, diphe-tRNA is synthesized in the absence of elongation factors, whereas the extensive synthesis of oligophe-tRNA (with more than two phe residues per molecule) depends on S2 factor and GTP (306) . (iv) S2 factor, in the presence of ribosomes, cleaves GTP into GDP and Pi; this activity is stimulated by poly U and tRNA (75, 281, 282) .
The following are some of the results and considerations which support the view that GTP cleavage by S2 and ribosomes is connected to protein synthesis. (i) Fusidic acid, a steroidal antibiotic, inhibits both ribosome-dependent guanosine triphosphatase activity of S2 factor and translocation (306, 381) . Fusidic acid-resistant E. coli mutants were obtained, and it was established that fusidic acid sensitivity or resistance is localized in the S2 factor (179) . (ii) GMPPCP (the GTP analogue with a methylene bridge between the f3 and y phosphorus atoms) does not substitute for GTP in translocation; actually, in the presence of GTP, it acts as an inhibitor (44, 101, 142, 152, 306) .
The incubation of ribosomes at elevated temperatures prior to using them in the guanosine triphosphatase assay in the presence of the S2 factor results in the uncoupling of GTP cleavage from peptide synthesis; the rate of GTP cleavage increases slightly, whereas the rate of protein synthesis decreases sharply (75, 282) .
Results were presented in an earlier section to indicate that GTP is cleaved in the course of peptide chain elongation after the attachment of AA-tRNA to the ribosomes but before peptide bond formation (296, 344) . This guanosine triphosphatase activity of the Si and S3 factors was first examined in a system free of S2 activity (296) . In more recent experiments, S2 was also included in the reaction mixtures. It was established that the GTP added to the system in the form of the Ss-GTP-AA-tRNA complex does not make translocation possible (297) . Thus, at least in the in vitro system with purified separated elongation factors, not less than two molecules of GTP are cleaved for the addition of each aminoacyl residue to the peptidyl-tRNA chain.
Efforts to establish the existence of a highenergy intermediate, whose formation is catalyzed by GTP and S2 factor, have so far not been successful (281) .
The availability of fusidic acid-resistant E. coli mutants (179) and other mutants with a thermosensitive S2 factor (387) will soon lead to the mapping of the chromosomal site of the gene specifying S2 .
Problems Arising from the Dual Specificities of the AUG and GUG Codons As initiation codons, AUG and GUG specify fMet-tRNAF in the E. coli system. As codons for internal aminoacyl residues of the peptide chain, however, AUG stands for Met-tRNAM and GUG for Val-tRNA (357) . The dual specificities of AUG and GUG raise the question of how mixups of Val-tRNA, fMet-tRNAF, and MettRNAF are avoided in protein synthesis. The outline of the answer is apparently the following. Val-tRNA and Met-tRNAF do not serve as initiators since they are not recognized by initiation factors. Furthermore, fMet-tRNAF does not participate in elongation; having its a-amino group blocked, it cannot serve as a peptidyl residue acceptor. A more difficult problem arises with the methionyl residues (in Met-tRNAF) which have a free a-amino group and, in principle, could thus be mistakenly incorporated in the place of valine in response to GUG codons in chain elongation. Studies with in vitro systems [in which random poly(U, G) or poly(U, A, G) were used as mRNA] indicate, however, that MettRNAF (unformylated) does not serve as a source of methionyl residues for internal positions of the peptide chain (238) .
The avoidance of this mistake apparently may be accounted for by the substrate specificity of the chain elongation factors S&. and SI; most and possibly all AA-tRNAs, including Met-tRNAM, do form complexes with the factors S3 and Si in the presence of GTP, whereas fMet-tRNAF and Met-tRNAF do not (295) . The AA-tRNA-GTP-S3 complexes are intermediates in AA-tRNA binding to the ribosomes. Thus, the lack of complex formation with Met-tRNAF may explain why Met-residues (from Met-tRNAF) are not inserted into internal positions of the peptide chain in response to GUG codons.
The fact that Met-tRNAM does form a com- plex with the elongation factors, whereas MettRNAF does not, indicates that the factors discriminate against tRNAF PEPTIDE CHAIN TERMINATION During chain elongation, the growing polypeptide chain remains linked to tRNA and bound to the mRNA-ribosome complex. After completion, the polypeptide is released from both of these bonds in the course of a composite process called peptide chain termination (116, 191, 203, 376, 425) . Termination is apparently triggered when in the course of the movement of the ribosome along the mRNA a chain termination signal is reached at the A site of the 30S subunit (Fig. 3) . It is believed that the codons UAA, UAG, and UGA (which are designated as nonsense codons) may serve as chain termination signals (38, 333, 404, 405) . Two release factors (R1 and R2) were found to be involved in this process. R, is specific for termination coded by UAA or UAG, and R2 for that coded by UAA or UGA (58, 63, 339) . After release of the polypeptidyl-tRNA, the mRNAribosome complex falls apart, giving rise to subunits (337, 403 (43, 355) , and a series of adjacent UAG or UGA codons in a polynucleotide; e.g., poly (U-A-G) or poly (U-G-A) does not direct in vitro amino acid incorporation (178) . [Actually, these two polynucleotides do direct the formation of two homopeptides each, but these homopeptides are specified by the other codons in the RNA, (i.e., AGU, GUA, GAU, and AUG).] When occurring in mRNA, the nonsense codons specify termination; e.g., the synthetic oligonucleotide AUG-UUUUAA directs the formation of fMet-phenylalanine [not linked to tRNA (203) ]. RNA from mutants of the bacteriophages f2 or R17 with a UAG codon within the gene specifying the coat protein promotes the synthesis in vitro of a coat protein fragment (402) , whereas RNA from the corresponding wild-type phages directs the formation of the complete coat protein in vitro just as it does in vivo (272) . The approaches used in identifying the nonsense codons and in deciphering their nucleotide sequences were reviewed recently (117) .
Release Factors and the Mechanism of Termination
Most of the information about the mechanism of chain termination was obtained in two assay systems. In one of these, RNA from a mutant R17 or f2 phage with a UAG nonsense codon early in the coat protein gene was used as the messenger. In vitro, this messenger directs the synthesis of the free (not tRNA-linked) amino terminal hexapeptide of the coat protein (40, 58, 425) . A cell-free system was prepared including only those AA-tRNA species which are needed for forming the hexapeptide. In this system, RNA from wild-type phage directs the formation of hexapeptidyl-tRNA, whereas RNA from the nonsense mutant promotes free hexapeptide synthesis (40, 58) . Thus, if a codon is untranslatable in consequence of the lack of a required AA-tRNA, this leads to the stoppage of peptide chain propagation but not to chain termination. The fact that, in the presence of the mRNA from a nonsense mutant, chain termination occurs even in the absence of all tRNAs except the six species added suggests that if RNA is involved in chain termination, it is not contained in the tRNA fraction (40, 58, 112, 352) .
A substrate for studying the mechanism of termination was prepared in the following way (58) . The formation of a hexapeptidyl-tRNA as specified by the phage mutant RNA was blocked at the pentapeptidyl-tRNA stage by omitting from the in vitro system the amino acid coded by codon six. The ribosome-mRNA-pentapeptidyltRNA complex was then separated from the supernatant fraction by centrifugation and the AA-tRNA needed to complete the hexapeptidyltRNA was added in the presence of GTP. The last amino acid became then added to the coat protein fragment. The resulting hexapeptidyltRNA remained attached to the mRNA-ribosome complex. This product made possible the study of the unique requirements of the release step. It was found that the release of free hexapeptide from this complex depends on a component from the supernatant fraction. This component was designated release factor (R factor) (58) .
Recently, another convenient termination assay was developed. AUG, fMet-tRNA, and ribosomes were incubated to form an AUG-fMettRNA-ribosome complex. The release of formylmethionine from this complex is promoted in the presence of a crude R-factor preparation by each of the three nonsense codons added in the form of triplets (63) . By using this test, the R-factor preparation was separated into two components; R1 catalyzes chain termination in response to UAA or UAG, and R2 in response to UAA or UGA (339) . The release of formylmethionine from fMet-tRNA by the R factors depends strictly on ribosomes.
The codon recognition pattern of R1 resembles that found with some species of tRNA. The molecule interacting with A at the 3' terminal nucleotide position of the mRNA codon also interacts with G in this position. However, the codon recognition by R2 has a pattern not found with any tRNA species so far. The R factors are nondialyzable and are inactivated on incubation with trypsin and N-ethylmaleimide, but not by ribonuclease. Thus, R1 and R2 behave like proteins with free sulfhydryl groups (339; see also 400) .
The fact that the formylmethionine release from the ribosome in response to terminator codons is inhibited by tetracycline may suggest that these codons exert their terminating activity at the same ribosomal site of the 30S subunit where, in the course of elongation, AA-tRNA is attached. The lack of effect of fusidic acid on the release indicates that translocation, as catalyzed by the S2 factor, is not involved in the process (339 (135) .] Subsequently, asparagine is added and, thus, synchronous translation of the coat protein gene ensues. The fate of the '2P-f2-RNA-ribosome complexes can be monitored by determining the amount of labeled RNA sedimenting as a complex with ribosomes (at the 80S region) and the amount sedimenting as free 32P-RNA or 32P-RNA attached to the 30S subunit (30S region and lighter). By using this technique, it was established that phage RNA and the polypeptide being synthesized rapidly disappear from the complex with the ribosome after translation of nonsense codons in the coat protein gene.
These observations seem to indicate that termination results in dissociation of the mRNA from the ribosome or, at least, dissociation of the 50S subunit, leaving behind an mRNA-30S subunit complex.
The release of the f2 RNA from the complex is rapid, but only partial (about 20%), after termination at the end of the coat protein gene (in experiments in which the reattachment of 32p_ RNA to ribosomes is blocked by added excess unlabeled f2 RNA). It is possible that this incomplete release reflects the translation of a subsequent gene on the mRNA by the same ribosome (or at least the same 30S subunit) which just completed the translation of the previous gene. Incomplete release occurs, perhaps, if the termination signal is near to an initiator codon (403) . (For a discussion of related subjects, see references 57, 98, 225, 335, and 426.)
The hypothetical schemes concerning the fate of ribosomes in the chain termination complex (complex VII in Fig. 3 ) after the release of the completed polypeptide can be divided arbitrarily into two classes: (i) ribosomes released as free subunits and (ii) ribosomes released as 70S particles which subsequently dissociate into subunits (2a, 186, 337) . If, among the products of chain termination, free 70S ribosomes (i.e., free of mRNA, peptidyl-tRNA, and fMet-tRNA) could be demonstrated, this would rule out the first class and be consistent with the second. 70S particles (in addition to subunits and polyribosomes) have been detected in cell lysates (186, 228a, 309, 310, 325, 337) . However, although a 70S particle (at least in principle) may be a free ribosome, it may also be a monosome (i.e., a complex of mRNA with a single ribosome with attached peptidyl-tRNA) or an initiation complex (a complex of mRNA with a single ribosome with attached fMet-tRNA).
According Further studies on the fate of the termination complex, which are underway in several laboratories, will help to resolve these apparent discrepancies.
PROBLEMS AND CONCLUSIONS
The following are a few of the outstanding problems in protein synthesis.
AA-tRNA synthetases. The principal aim is to understand the molecular basis of the high specificity of these enzymes for their cognate amino acid and tRNA. X-ray diffraction analysis of the enzymes of tRNAs, and, hopefully, of AA-tRNA synthetase of tRNA complexes may contribute to the solution of this problem. The detailed kinetics of the sequence of steps leading to the amino-acylation of tRNA remains to be determined. It is noteworthy that, although the reactions catalyzed by all the AA-tRNA synthetases are analogous, the various enzymes in this group differ in many properties (e.g., molecular weight, effect of SH-reagents, etc.).
Tranfer RNA. Although the nucleotide sequences of more than a dozen tRNA species have been determined, the anticodon and the CCA terminus are still the only regions of the molecule whose functions are established. The sites on the tRNA involved in recognition by the AA-tRNA synthetase, by the various tRNA binding sites of the ribosome, and by initiation and elongation factors all remain to be identified. In addition to X-ray diffraction studies, experiments with chemically or genetically altered tRNA molecules may facilitate the identification.
Much remains to be learned about the biosynthesis of tRNA. The chemical synthesis of tRNAspecifying genes (62, 342) may provide the basis for extensive studies on the transcription of these genes and on the modification of the products of the transcription (presumably the tRNA precursors) by the various modifying enzymes.
Further studies are needed on the role of tRNA in the regulation of protein synthesis, on the function of virus-specified tRNAs in the metabolism of virus-infected cells, and on the possible role of tRNA in differentiation and hormone action. The involvement of tRNA in bacterial cell wall synthesis proves that the function of this class of macromolecules is not restricted to protein synthesis.
Ribosomes. The chemical characterization of ribosomal proteins, together with the reconstitution of the 30S subunit, may provide the basis for the elucidation of the specific roles of the particular ribosomal proteins in ribosome function. It is probable that a number of these proteins are serving as binding sites for AA-tRNA and peptidyl-tRNA and for initiation, elongation, and release factors. It is likely that eventually the techniques of electron microscopy and X-ray diffraction will become applicable to ribosome structure analysis.
Peptide chain initiation. Sequencing of natural mRNAs and of the RNAs of single-stranded RNA bacteriophages may be required for establishing the nucleotide sequence of ribosome attachment sites, peptide chain initiation and termination signals, and intercistronic regions.
Instead of determining the complete nucleotide sequence of these RNAs, it may suffice to sequence those regions to which the ribosomes attach when initiating translation at various initiation sites of polygenic mRNAs. Presumably, attached ribosomes may protect the attachment sites on the mRNA against digestion by nucleases (377), and this may make the selective sequencing of such sites possible. Which component of the protein-synthesizing machinery (ribosomal protein, initiationfactors, fMet-tRNA,etc.) recognizes the initiation signals remains to be established.
The availability of pure initiation factors from E. coli should assist in determining the intermediate steps in initation.
The process of initiation, the nature of the initiator tRNA, and the initiation signals in the cytoplasm of eukaryotic cells are not known at this time.
Peptide chain elongation. The requirement for GTP and the cleavage of GTP to GDP and Pi in the course of the addition of each aminoacyl residue to the growing peptide chain has been known for some time. Energetically, there seems to be no need for the free energy of GTP for peptide bond formation since the AF of the peptidyl donor-peptidyl-tRNA (estimated to be -7 kcal/mole) is ample for the formation of the peptide bond [AF, -3 kcal/mole (218) ]. Indeed, GTP is apparently not needed for the actual formation of the peptide bond in vitro.
The step in elongation that was first shown to require GTP is translocation (15, 75, 142, 218, 281) . There is cause to believe that the GTP molecule needed for this step is cleaved prior to, or concomitantly with, the events in translocation. Recent data indicate that GTP is also required for AA-tRNA binding to the ribosomemRNA complex and that cleavage of this GTP molecule may be a prerequisite for peptide bond formation (296, 344) . Results of in vitro experiments suggest that the GTP cleaved in the course of AA-tRNA binding cannot serve in the translocation; i.e., at least two GTP molecules may be cleaved in the in vitro system for each aminoacyl residue incorporated into the growing polypeptide (297) .
It may be too early to conclude that two molecules of GTP are cleaved for each peptide bond formed in vivo, too. One of the causes warranting this caution is that in vitro conditions may create artifacts: The guanosine triphosphatase activity of S2 (the translocase) as studied in vitro is apparently uncoupled from peptide bond formation. [More precisely, the S2 factor catalyzes the cleavage of GTP just in the presence of ribosomes) (75) ]. It may well be that in vivo this is not the case.
It is an intriguing possibility, however, that translocation is a two-step process and that the cleavage of the first GTP may be needed to drive its first step. In the first step of such a hypothetical translocation model (after AA-tRNA binding and concomitantly with peptide bond formation), the 30S subunit, schematically speaking, moves along the mRNA the length of one codon, leaving the 50S subunit behind. (In the resulting intermediate, the discharged tRNA may be bound to the P site of the 50S subunit and the peptidyl-tRNA to the P site of the 30S subunit and to the A site of the 50S subunit.) In the second step (in which S2 factor is involved and a second molecule of GTP is cleaved) the discharged tRNA is released, the 50S subunit is realigned with the 30S subunit, and the peptidyltRNA is shifted (from the A site to the P site of the 50S subunit). A two-step translocation model involving an intermediate similar to the one in this outline was proposed recently (41) .
It remains to be established whether the GTP molecule(s) cleaved in the course of peptide chain elongation donate Pi or GDP to form a high-energy intermediate with a component of the translation machinery or whether the GTP(s) acts as an allosteric effector. It should be noted that the free energy of GTP could, in principle, drive ribosome movement even in an allosteric fashion (i.e., with no high energy intermediate of the X P or GDP -X type involved). If binding of GTP would cause a conformational change of a protein and the cleavage of GTP would reverse the change, then a ratchet-type unidirectional movement could result from the repeated binding of GTP and its removal by cleavage to GDP and Pi.
Whatever the case, the mechanism of the movement of the ribosome relative to the mRNA and the role of GTP in this process are perhaps the most exciting unsolved problems in translation. A hypothetical model of ribosome function was proposed some time ago (358) .
Peptide chain termination. Both genetic and biochemical studies indicate that each of the UAA, UAG, and UGA codons can serve as a signal in mRNA for chain termination. It is believed, however, that the normal and frequently used termination codon in vivo is UAA, and that UAG and UGA are rarely used, if at all. This assumption is based on the following facts and considerations. By genetic manipulation (more specifically, by introduction of nonsense suppressors) E. coli strains can be constructed in which UAG or UGA is frequently read as a chain elongation codon specifying an amino acid, instead of serving as a termination signal. Nevertheless, such strains grow normally.
It is argued that if UAG or UGA would be principal chain termination signals, the growth of such strains would be adversely affected.
On the other hand, no strains have been found in which UAA would be translated with a high probability as an amino acid. Thus, it is believed that such strains may not be viable and, consequently, that UAA may be indispensable as a chain terminator codon (117) .
The fact that two release factors are maintamied in the cell, one of which is specific for UAG (in addition to UAA) and the other for UGA (in addition to UAA), may suggest that UAG and UGA are used as normal termination signals, even if rarely (339) .
Sequencing of natural mRNAs will be needed to establish definitely the nature of the termination signals.
It also remains to be seen whether the release factors do recognize the termination signals directly, or whether other molecules, which in turn interact with the appropriate species of release factors (339) , are involved in this process.
In conclusion, it should be noted that the time is ripe for the application of the powerful methods of genetic analysis to the protein-synthesizing machinery. The first steps in this direction have been taken (129, 140, 179, 274, 337, 387) . The selection of specific mutants, a prerequisite for such genetic studies, shall be greatly facilitated by the use of antibiotics [known to affect particular components of the machinery as selective agents (406)].
The scope of this review has been restricted to microbial protein synthesis. It is obvious that the knowledge obtained by examining this pathway in microorganisms should accelerate the progress of similar investigations in higher organisms. The latter may contribute ultimately to the understanding of such diverse phenomena as antibody synthesis, hormone action, and differentiation.
